Detalles de la búsqueda
1.
Cooling inflammation while potentiating immune checkpoint inhibition: Enhancing the benefit-risk ratio of immuno-oncology therapy.
Proc Natl Acad Sci U S A
; 121(9): e2400431121, 2024 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38354255
2.
Targeting cytochrome P450-dependent cancer cell mitochondria: cancer associated CYPs and where to find them.
Cancer Metastasis Rev
; 37(2-3): 409-423, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30066055
3.
Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial.
Breast Cancer Res Treat
; 165(2): 329-341, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28612225
4.
Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 16(15): 1556-1568, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26482278
5.
Endothelial dysfunction in breast cancer survivors on aromatase inhibitors: changes over time.
Cardiooncology
; 10(1): 27, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38693561
6.
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.
Clin Cancer Res
; 30(4): 729-740, 2024 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38109213
7.
Endothelial Dysfunction in Breast Cancer Survivors on Aromatase Inhibitors: Changes over Time.
Res Sq
; 2023 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37066265
8.
CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET).
J Biol Chem
; 286(20): 17543-59, 2011 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21402692
9.
Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial.
Breast Cancer Res Treat
; 166(1): 327-328, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28884461
10.
A Neoadjuvant Chemotherapy Trial for Early Breast Cancer is Impacted by COVID-19: Addressing Vaccination and Cancer Trials Through Education, Equity, and Outcomes.
Clin Cancer Res
; 27(16): 4486-4490, 2021 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34108186
11.
Lymphadenopathy after the third Covid-19 vaccine.
Curr Probl Cancer Case Rep
; 4: 100127, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34746900
12.
Recent advances in neoadjuvant therapy for breast cancer.
Fac Rev
; 10: 2, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33659921
13.
Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor-Positive/HER2-Negative Advanced or Metastatic Breast Cancer.
Clin Cancer Res
; 27(12): 3329-3338, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33820779
14.
Gene silencing for epidermal growth factor receptor variant III induces cell-specific cytotoxicity.
Mol Cancer Ther
; 7(11): 3586-97, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19001441
15.
Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.
NPJ Breast Cancer
; 5: 2, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30675512
16.
Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.
NPJ Breast Cancer
; 4: 26, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30131975
17.
Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer.
Clin Cancer Res
; 12(6): 1883-96, 2006 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16551874
18.
Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial.
Eur J Cancer
; 76: 205-215, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28360015
19.
Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria.
Cell Chem Biol
; 24(10): 1259-1275.e6, 2017 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-28919040
20.
HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes.
Oncogene
; 24(15): 2585-8, 2005 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-15735736